476Cognitive dysfunction with prominent involvement of memory, sustained attention, executive functions, and information processing speed is a prevalent disabling neuropsychologic symptom of multiple sclerosis (MS) with prevalence of 40-65%.1 It is associated with significant disability and impaired quality of life, adversely affecting daily activity and role fulfillment in work and social life, independently from physical disability, [2][3][4] with profound socioeconomic consequences. Cognitively impaired MS patients experience higher rate of unemployment, 4-6 and divorce 5 than non-impaired MS peers. They are more likely to be involved in accidents, including motor vehicle crashes.7-9 Difficulties in learning and ABSTRACT: Background: Cognitive dysfunction is one of the common clinical symptoms in multiple sclerosis (MS), but there is no effective treatment for it. Objective: The aim of this study was to evaluate the effect of rivastigmine in treating memory and cognitive dysfunction in MS. Methods: A single-center double-blind placebo-controlled randomized clinical trial conducted from October 2005 to February 2007. Sixty definite MS patients with cognitive impairment age 16 to 54 years were randomly allocated to receive a 12-week treatment course of either rivastigmine (1.5 mg once a day increment over 4 weeks to 3 mg twice daily) or placebo. Response to treatment was assessed by the Wechsler Memory Scale (WMS) at baseline and 12 weeks after start of therapy. Results: A slight, but significant memory improvement occurred in both groups. Of the 30 patients treated with rivastigmine, the mean (SD) WMS general memory score increased from 60.3 (4.2) at baseline to 64.9 (5.3) at the end of study period (P<0.001). Correspondingly, in the 30 patients treated with placebo, the mean (SD) WMS general memory score increased from 60.5 (4.9) to 64.5 (3.7) (P < 0.001). The average WMS general memory score at the end of trial did not changed between rivastigmine and placebo group (mean difference, 0.4; 95% CI, -2.0, 2.8). Conclusion: No significant differences were seen between rivastigmine and placebo on the mean (SD) WMS general memory score. A larger multicenter study of rivastigmine in MS is warranted in order to more definitely assess the efficacy of this intervention.RÉSUMÉ: Effets de la rivastigmine sur la mémoire et la cognition dans la sclérose en plaques. Contexte : La dysfonction cognitive est l'un des symptômes cliniques fréquents dans la sclérose en plaques (SEP), pour lequel il n'existe aucun traitement efficace. Objectif : Le but de cette étude était d'évaluer l'effet de la rivastigmine dans le traitement de la dysfonction mnésique et cognitive de la SEP. Méthodes : Nous avons effectué un essai clinique randomisé à double insu, contrôlé par placebo, dans un seul centre entre octobre 2005 et février 2007. Soixante patients atteints de SEP certaine avec atteinte cognitive, âgés de 16 à 54 ans, ont été randomisés à recevoir un traitement par la rivastigmine (1,5 mg une fois par jour avec augmentation progressiv...
No abstract
Background: Persistent depressive disorder (PDD) is a chronic problem that is more prevalent among women than men. Various studies have revealed that these people experience many problems in their interpersonal relationships, which increase their suffering. Objectives: The present study was done to identify how people suffering from PDD experience interpersonal relationships that often seem troubled and broken. Methods: A phenomenological approach was adopted for this qualitative study. For this purpose, in-depth interviews were conducted with 21 individuals with PDD, focusing on exploring their experience and suffering in interpersonal relationships. All interviews were recorded and transcribed, and the transcripts were analyzed using Giorgi’s phenomenological descriptive method. Results: In general, five main themes and 16 sub-themes emerged. The main themes were: (1) Feeling empty of love and compassion; (2) feeling ignored; (3) ignoring others’ needs, conditions, and suffering; (4) feeling of being annoying to others; and (5) feeling confused and helpless in relationships. Conclusions: It seems that all five themes convey the message that these individuals demonstrate less skill in feeling compassion and receiving it from others. Therefore, it appears that long-term compassion-based interventions can effectively reduce the interpersonal suffering of these individuals. It should be noted that although these themes have commonalities in different cultural contexts, the culture can influence the content and intensity of these feelings.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.